Global Patent Index - EP 1315837 A2

EP 1315837 A2 20030604 - 5-HYDROXYTRYPTAMINE RECEPTOR GENE POLYMORPHISMS AND RESPONSE TO TREATMENT

Title (en)

5-HYDROXYTRYPTAMINE RECEPTOR GENE POLYMORPHISMS AND RESPONSE TO TREATMENT

Title (de)

5-HYDROXYTRYPTAMIN GENREZEPTOR POLYMORPHISMEN UND AUSSICHT AUF BEHANDELUNG

Title (fr)

POLYMORPHISMES DU GENE DU RECEPTEUR DE LA 5-HYDROXYTRYPTAMINE ET REPONSE AU TRAITEMENT

Publication

EP 1315837 A2 20030604 (EN)

Application

EP 01968309 A 20010831

Priority

  • US 0127066 W 20010831
  • US 23037800 P 20000906

Abstract (en)

[origin: WO0220841A2] Correlations between polymorphisms in the 5-hydroxytryptamine 3 receptor gene, and/or polymorphisms in the UGT1A4 gene, and a subject's phenotypic response to treatment with 5-hydroxytryptamine ligands are described. Methods of screening subjects to aid in treatment, methods of screening 5HT ligands, and methods of treatment are presented.

IPC 1-7

C12Q 1/68; C07K 14/705; A61K 31/415

IPC 8 full level

A61K 31/4178 (2006.01); A61K 31/437 (2006.01); A61K 31/439 (2006.01); A61K 45/00 (2006.01); A61P 1/00 (2006.01); A61P 1/10 (2006.01); A61P 1/12 (2006.01); A61P 43/00 (2006.01); C12N 15/09 (2006.01); C12Q 1/68 (2006.01); C12Q 1/6883 (2018.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01)

CPC (source: EP)

A61P 1/00 (2017.12); A61P 1/10 (2017.12); A61P 1/12 (2017.12); A61P 43/00 (2017.12); C12Q 1/6883 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01)

Citation (search report)

See references of WO 0220841A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0220841 A2 20020314; WO 0220841 A3 20020919; AU 8856401 A 20020322; EP 1315837 A2 20030604; JP 2004508056 A 20040318

DOCDB simple family (application)

US 0127066 W 20010831; AU 8856401 A 20010831; EP 01968309 A 20010831; JP 2002525846 A 20010831